SCHEMBL30879224

SCHEMBL30879224

COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.75
▸ KDR P35968 2/20 0.72
▸ BRAF P15056 2/20 0.72
▸ CIT O14578 1/20 0.72
▸ GAK O14976 1/20 0.72
▸ EPHB6 O15197 1/20 0.72
▸ ABCC4 O15439 1/20 0.72
▸ DAPK3 O43293 1/20 0.72
▸ RIPK2 O43353 1/20 0.72
▸ NR1I2 O75469 1/20 0.72
▸ RPS6KA4 O75676 1/20 0.72
▸ STK17B O94768 1/20 0.72
▸ STK10 O94804 1/20 0.72
▸ PRKD3 O94806 1/20 0.72
▸ ABCB11 O95342 1/20 0.72
▸ MAP4K4 O95819 1/20 0.72
▸ CHEK2 O96017 1/20 0.72
▸ ABL1 P00519 1/20 0.72
▸ ERBB2 P04626 1/20 0.72
▸ LCK P06239 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30213428 1.00 EGFR (0.75) EGFRKDRBRAFCITGAK
SCHEMBL4220279 1.00 EGFR (0.75) EGFRKDRBRAFCITGAK
SCHEMBL30119557 0.91 EGFR (0.61) EGFRKDRBRAFCITGAK
SCHEMBL28538015 0.91 EGFR (0.61) EGFRKDRBRAFCITGAK
SCHEMBL14971204 0.91 EGFR (0.74) EGFRKDRBRAFCITGAK
SCHEMBL15078687 0.91 EGFR (0.74) EGFRKDRBRAFCITGAK
SCHEMBL14971257 0.90 EGFR (0.70) EGFRKDRBRAFCITGAK
SCHEMBL25341847 0.89 EGFR (0.72) EGFRKDRBRAFCITGAK
SCHEMBL31502861 0.89 EGFR (0.72) EGFRKDRBRAFCITGAK
SCHEMBL4226298 0.89 EGFR (0.64) EGFRKDRERBB2EPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612149-A1 PYRIDO[2,3-D]PYRIMIDIN-2-AMINE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 — — EP disclosed
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 — — EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 — — WO disclosed
Send feedback